RecruitingNCT06119243

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control

Sponsor

The University of New South Wales

Enrollment

230 participants

Start Date

Mar 21, 2023

Study Type

OBSERVATIONAL

Conditions

Myopia

Summary

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Eligibility

Min Age: 4 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Vivior for people with myopia. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 4 Years to 14 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVivior

The Vivior is a wearable clip-on sensor that objectively quantifies near viewing distance and duration, and ambient illumination. The Vivior will be attached to the spectacles frame of children undergoing myopia control treatment.